Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 6, 2009, Pages

  Yoshikawa, Noritada ^a   Nagasaki, Masao ^a   Sano, Motoaki ^b,c   Tokudome, Satori ^b   Ueno, Kazuko ^a   Shimizu, Noriaki ^a   Imoto, Seiya ^a   Miyano, Satoru ^a   Suematsu, Makoto ^b   Fukuda, Keiichi ^b   Morimoto, Chikao ^a   Tanaka, Hirotoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cardiovascular system; Cylooxygenase 2; Endocrinology; KLF15; Phospholipase A2

Indexed keywords

ALDOSTERONE; BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE; CORTIVAZOL; CYCLOOXYGENASE 2; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; KRUPPEL LIKE FACTOR; LIGAND; MESSENGER RNA; MIFEPRISTONE; PHOSPHOLIPASE A2; PROSTAGLANDIN; SMALL INTERFERING RNA;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HEART MUSCLE METABOLISM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLOOXYGENASE 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HORMONE ANTAGONISTS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIGANDS; MIFEPRISTONE; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOLIPASES A2; PREGNATRIENES; PROTEIN BINDING; RATS; RECEPTORS, GLUCOCORTICOID; TRANSFECTION;

EID: 66849128246     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90767.2008     Document Type: Article

References (53)

1. Almon RR, DuBois DC, Yao Z, Hoffman EP, Ghimbovschi S, Jusko WJ. Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol Genomics 30: 282-299, 2007. (Pubitemid 47296188)
2. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268-275, 1987. (Pubitemid 17095145)
3. Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res 100: 1686-1695, 2007. (Pubitemid 46987860)
4. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. J Am Med Assoc 299: 1291-1305, 2008.
5. Brotman DJ, Girod JP, Garcia MJ, Patel JV, Gupta M, Posch A, Saunders S, Lip GY, Worley S, Reddy S. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 90: 3202-3208, 2005. (Pubitemid 41014276)
6. Czerwinski SM, Kurowski TT, McKee EE, Zak R, Hickson RC. Myosin heavy chain turnover during cardiac mass changes by glucocorticoids. J Appl Physiol 70: 300-305, 1991.
7. Davies NM, Jamali F. COX-2 selective inhibitors cardiac toxicity: getting to the heart of the matter. J Pharm Pharm Sci 7: 332-336, 2004. (Pubitemid 41528882)
8. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56: 820-830, 2007.
9. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev 86: 465-514, 2006.
10. de Vries WB, van der Leij FR, Bakker JM, Kamphuis PJ, van Oosterhout MF, Schipper ME, Smid GB, Bartelds B, van Bel F. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr Res 52: 900-906, 2002. (Pubitemid 35379471)
11. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210, 2002.
12. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, Pfister O, Cui L, Kumar A, Lin Z, Sen-Banerjee S, Das H, Petersen CA, Mende U, Burleigh BA, Zhu Y, Pinto YM, Liao R, Jain MK. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 104: 7074-7079, 2007. (Pubitemid 47186011)
13. Freerksen DL, Hartzell CR. Glucocorticoid stimulation of metabolism and glycerol-3-phosphate dehydrogenase activity in cultured heart cells. J Cell Physiol 126: 206-210, 1986. (Pubitemid 16185558)
14. Gardner DG, Wu JP, LaPointe MC, Hedges BK, Deschepper CF. Expression of the gene for the atrial natriuretic peptide in cardiac myocytes in vitro. Cardiovasc Drugs Ther 2: 479-486, 1988. (Pubitemid 19045698)
15. Gray S, Feinberg MW, Hull S, Kuo CT, Watanabe M, Sen-Banerjee S, DePina A, Haspel R, Jain MK. The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J Biol Chem 277: 34322-34328, 2002. (Pubitemid 35056255)
16. Guder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Stork S. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 115: 1754-1761, 2007. (Pubitemid 46648612)
17. Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C. Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol 63: 1012-1020, 2003. (Pubitemid 36529919)
18. Hutson SM, Sweatt AJ, Lanoue KF. Branched-chain [corrected] amino acid metabolism: implications for establishing safe intakes. J Nutr 135: 1557S-1564S, 2005. (Pubitemid 40791670)
19. Iwatani S, Van Dien S, Shimbo K, Kubota K, Kageyama N, Iwahata D, Miyano H, Hirayama K, Usuda Y, Shimizu K, Matsui K. Determination of metabolic flux changes during fed-batch cultivation from measurements of intracellular amino acids by LC-MS/MS. J Biotechn 128: 93-111, 2007. (Pubitemid 44960516)
20. James CG, Ulici V, Tuckermann J, Underhill TM, Beier F. Expression profiling of dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC Genomics 8: 205, 2007. (Pubitemid 47097347)
21. Kanda F, Okuda S, Matsushita T, Takatani K, Kimura KI, Chihara K. Steroid myopathy: pathogenesis and effects of growth hormone and insulin-like growth factor-I administration. Horm Res 56, Suppl 1: 24-28, 2001. (Pubitemid 34062892)
22. Kniss DA, Burry RW. Glucocorticoid hormones inhibit DNA synthesis in glial cells cultured in chemically defined medium. Exp Cell Res 161: 29-40, 1985. (Pubitemid 16192176)
23. Kodde IF, van der Stok J, Smolenski RT, de Jong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol 146: 26-39, 2007. (Pubitemid 46186082)
24. Komamura K, Shirotani-Ikejima H, Tatsumi R, Tsujita-Kuroda Y, Kitakaze M, Miyatake K, Sunagawa K, Miyata T. Differential gene expression in the rat skeletal and heart muscle in glucocorticoid-induced myopathy: analysis by microarray. Cardiovasc Drugs Ther 17: 303-310, 2003. (Pubitemid 37500181)
25. Kurowski TT, Czerwinski SM. Glucocorticoid modulation of cardiac mass and protein. Med Sci Sports Exerc 22: 312-315, 1990. (Pubitemid 20202802)
26. La Mear NS, MacGilvray SS, Myers TF. Dexamethasone-induced myocardial hypertrophy in neonatal rats. Biol Neonate 72: 175-180, 1997. (Pubitemid 27397374)
27. Lefer AM. Influence of corticosteroids on mechanical performance of isolated rat papillary muscles. Am J Physiol 21: 518-524, 1968.
28. Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovasc Res 70: 555-565, 2006.
29. Liu SF, Newton R, Evans TW, Barnes PJ. Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci (Lond) 90: 301-306, 1996. (Pubitemid 126425349)
30. Menconi M, Fareed M, O'Neal P, Poylin V, Wei W, Hasselgren PO. Role of glucocorticoids in the molecular regulation of muscle wasting. Crit Care Med 35: S602-S608, 2007. (Pubitemid 47312202)
31. Mendez M, LaPointe MC. Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes. Hypertension 39: 382-388, 2002. (Pubitemid 34165153)
32. Miller AL, Webb MS, Thompson EB. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells. Steroids 72: 673-681, 2007. (Pubitemid 47126562)
33. Narayanan N, Yang C, Xu A. Dexamethasone treatment improves sarcoplasmic reticulum function and contractile performance in aged myocardium. Mol Cell Biochem 266: 31-36, 2004. (Pubitemid 39562305)
34. Pazirandeh A, Xue Y, Prestegaard T, Jondal M, Okret S. Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. Faseb J 16: 727-729, 2002.
35. Penefsky ZJ, Kahn M. Inotropic effects of dexamethasone in mammalian heart muscle. Eur J Pharmacol 15: 259-266, 1971.
36. Phuc Le P, Friedman JR, Schug J, Brestelli JE, Parker JB, Bochkis IM, Kaestner KH. Glucocorticoid receptor-dependent gene regulatory networks (Abstract). PLoS Genet 1: e16, 2005.
37. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353: 1711-1723, 2005. (Pubitemid 41464710)
38. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, Holsboer F, Damm K. Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Mol Endocrinol 7: 597-603, 1993. (Pubitemid 23138168)
39. Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, Peuchmaur M, Tronche F, Farman N, Escoubet B, Benitah JP, Jaisser F. Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J 21: 3133-3141, 2007. (Pubitemid 47565533)
40. Sano M, Tokudome S, Shimizu N, Yoshikawa N, Ogawa C, Shirakawa K, Endo J, Katayama T, Yuasa S, Ieda M, Makino S, Hattori F, Tanaka H, Fukuda K. Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1alpha. J Biol Chem 282: 25970-25980, 2007. (Pubitemid 47372787)
41. Schlechte JA, Schmidt TJ. Use of [3H]cortivazol to characterize glucocorticoid receptors in a dexamethasone-resistant human leukemic cell line. J Clin Endocrinol Metab 64: 441-446, 1987. (Pubitemid 17020906)
42. Schulz R, Nava E, Moncada S. Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580, 1992.
43. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 6: 181-194, 2007. (Pubitemid 47324140)
44. Shimizu N, Ouchida R, Yoshikawa N, Hisada T, Watanabe H, Okamoto K, Kusuhara M, Handa H, Morimoto C, Tanaka H. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. Proc Natl Acad Sci USA 102: 8555-8560, 2005. (Pubitemid 40862774)
45. Stojadinovic O, Lee B, Vouthounis C, Vukelic S, Pastar I, Blumenberg M, Brem H, Tomic-Canic M. Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. J Biol Chem 282: 4021-4034, 2007. (Pubitemid 47084434)
46. Sun H, Sheveleva E, Xu B, Inoue H, Bowden TG, Chen QM. Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-β. Am J Physiol Cell Physiol 295: C915-C922, 2008.
47. Testa M, Rocca B, Spath L, Ranelletti FO, Petrucci G, Ciabattoni G, Naro F, Schiaffino S, Volpe M, Reggiani C. Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents. J Appl Physiol 103: 1412-1418, 2007. (Pubitemid 47605981)
48. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157: 545-559, 2007. (Pubitemid 350187371)
49. Wang JC, Shah N, Pantoja C, Meijsing SH, Ho JD, Scanlan TS, Yamamoto KR. Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev 20: 689-699, 2006.
50. Wang L, Feng ZP, Duff HJ. Glucocorticoid regulation of cardiac K+ currents and L-type Ca2+ current in neonatal mice. Circ Res 85: 168-173, 1999. (Pubitemid 29343315)
51. Whitehurst RM Jr, Zhang M, Bhattacharjee A, Li M. Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca(2+)current. J Mol Cell Cardiol 31: 1551-1558, 1999. (Pubitemid 29361121)
52. Yoshikawa N, Makino Y, Okamoto K, Morimoto C, Makino I, Tanaka H. Distinct interaction of cortivazol with the ligand binding domain confers glucocorticoid receptor specificity: cortivazol is a specific ligand for the glucocorticoid receptor. J Biol Chem 277: 5529-5540, 2002. (Pubitemid 34968604)
53. Yoshikawa N, Yamamoto K, Shimizu N, Yamada S, Morimoto C, Tanaka H. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor. Mol Endocrinol 19: 1110-1124, 2005. (Pubitemid 40594112)